EyePoint Pharmaceuticals

SEC Filing Details

Document Details

Form
Filing Date
Oct 29, 2018
Document Date
Oct 25, 2018
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
EyePoint Pharmaceuticals
Issuer
EyePoint Pharmaceuticals, Inc.
Filer
LANDIS JOHN B.
EyePoint Pharmaceuticals